Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: A 2012 calculation for a midwestern health referral region

Heart Rhythm

Volumn 11, Issue 5, 2014, Pages 849-855

  Hoang, Allen ^a   Shen, Changyu ^b   Zheng, James ^b   Taylor, Stanley ^b   Groh, William J ^a   Rosenman, Marc ^b   Buxton, Alfred E ^c   Chen, Peng Sheng ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arrhythmia; Defibrillator; Implantable cardioverter defibrillator; Sudden cardiac death; Utilization

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; COHORT ANALYSIS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT REFERRAL; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOM SAMPLE; SUDDEN CARDIAC DEATH; UNITED STATES; ARRHYTHMIAS, CARDIAC; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH, SUDDEN, CARDIAC; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; INCIDENCE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRENDS; UTILIZATION;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CONFIDENCE INTERVALS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INDIANA; MALE; MIDDLE AGED; PRIMARY PREVENTION; PROGNOSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; SURVIVAL RATE; VENTRICULAR FUNCTION, LEFT;

EID: 84899464006     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.02.019     Document Type: Article

References (27)

1. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators N Engl J Med 341 1999 1882 1890
2. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
3. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
4. A. Kadish, A. Dyer, and J.P. Daubert et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
5. G. Gregoratos, J. Abrams, and A.E. Epstein et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation 106 2002 2145 2161
6. D.P. Zipes, A.J. Camm, and M. Borggrefe et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J Am Coll Cardiol 48 2006 e247 e346
7. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen et al. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary Heart Rhythm 5 2008 934 955
8. B. Shah, A.F. Hernandez, L. Liang, S.M. Al-Khatib, C.W. Yancy, G.C. Fonarow, and E.D. Peterson Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry J Am Coll Cardiol 53 2009 416 422
9. J. Bradfield, A. Warner, and M.M. Bersohn Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center Pacing Clin Electrophysiol 32 Suppl 1 2009 S194 S197
10. B.D. Atwater, D. Dai, N.M. Allen-Lapointe, S.M. Al-Khatib, L.O. Zimmer, G.D. Sanders, and E.D. Peterson Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications Am Heart J 164 2012 750 755 e751
11. S.H. Chae, and T.M. Koelling Patient and physician determinants of implantable cardioverter defibrillator use in the heart failure population Congest Heart Fail 16 2010 141 146
12. D.B. Sims, L.I. Garcia, A. Mignatti, P.C. Colombo, M. Jones, N. Uriel, D.M. Mancini, and U.P. Jorde Utilization of defibrillators and resynchronization therapy at the time of evaluation at a heart failure and cardiac transplantation center Pacing Clin Electrophysiol 33 2010 988 993
13. U. Mezu, I. Ch, I. Halder, B. London, and S. Saba Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death Europace 14 2012 341 344
14. A.F. Hernandez, G.C. Fonarow, L. Liang, S.M. Al-Khatib, L.H. Curtis, K.A. LaBresh, C.W. Yancy, N.M. Albert, and E.D. Peterson Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure JAMA 298 2007 1525 1532
15. D.R. MacFadden, J.V. Tu, A. Chong, P.C. Austin, and D.S. Lee Evaluating sex differences in population-based utilization of implantable cardioverter-defibrillators: role of cardiac conditions and noncardiac comorbidities Heart Rhythm 6 2009 1289 1296
16. G. Lin, R.A. Meverden, D.O. Hodge, D.Z. Uslan, D.L. Hayes, and P.A. Brady Age and gender trends in implantable cardioverter defibrillator utilization: a population based study J Interv Card Electrophysiol 22 2008 65 70
17. K.L. Thomas, S.M. Al-Khatib, R.C. Kelsey 2nd, H. Bush, L. Brosius, E.J. Velazquez, E.D. Peterson, and F.R. Gilliam Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of
18. P.S. Chan, J.D. Birkmeyer, H.M. Krumholz, J.A. Spertus, and B.K. Nallamothu Racial and gender trends in the use of implantable cardioverter-defibrillators among Medicare beneficiaries between 1997 and 2003 Congest Heart Fail 15 2009 51 57
19. P.W. Groeneveld, P.A. Heidenreich, and A.M. Garber Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography J Am Coll Cardiol 45 2005 72 78
20. D.D. Matlock, P.N. Peterson, P.A. Heidenreich, F.L. Lucas, D.J. Malenka, Y. Wang, J.P. Curtis, J.S. Kutner, E.S. Fisher, and F.A. Masoudi Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry Circ Cardiovasc Qual Outcomes 4 2011 114 121
21. American Hospital Association Data 2013. Available at: http://www.ahadataviewer.com/quickreport/.
22. A.J. Epstein, D. Polsky, F. Yang, L. Yang, and P.W. Groeneveld Geographic variation in implantable cardioverter-defibrillator use and heart failure survival Med Care 50 2012 10 17
23. S. Saba, L.P. Ravipati, and A. Voigt Recent trends in utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States Pacing Clin Electrophysiol 32 2009 1444 1449
24. R. Havmoeller, K. Reinier, C. Teodorescu, A. Uy-Evanado, R. Mariani, K. Gunson, J. Jui, and S.S. Chugh Low rate of secondary prevention ICDs in the general population: multiple-year multiple-source surveillance of sudden cardiac death in the Oregon Sudden Unexpected Death Study J Cardiovasc Electrophysiol 24 2013 60 65
25. A.L. Miller, Y. Wang, J. Curtis, F.A. Masoudi, A.E. Buxton, and T.Y. Wang Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry Arch Intern Med 172 2012 64 67
26. Centers for Medicare & Medicaid Services. Decision Memo for Implantable Defibrillators. 2005. Available at: http://www.cms.gov/medicare- coverage-database/details/nca-decision-memo.aspx?NCAId=148&NCDId= 110&ncdver=3&NcaName=Implantable+Defibrillators&IsPopup=y&bc= AAAAAAAAEAAA&,.
27. J.M. Castellanos, L.M. Smith, P.D. Varosy, C. Dehlendorf, and G.M. Marcus Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey Heart Rhythm 9 2012 874 881